Ignite Creation Date:
2025-12-24 @ 10:37 PM
Ignite Modification Date:
2026-02-26 @ 5:45 PM
Study NCT ID:
NCT01527435
Status:
COMPLETED
Last Update Posted:
2016-04-06
First Post:
2012-01-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)
Sponsor:
The Retina Center of St. Louis County, PC
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
11-06-0044
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |